FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2037589733> ?p ?o ?g. }

• W2037589733 endingPage "1149" @default.
• W2037589733 startingPage "1144" @default.
• W2037589733 abstract "We aimed to compare the effects of the angiotensin II receptor blocker (ARB) olmesartan versus the calcium channel blocker (CCB) amlodipine on coronary endothelial dysfunction in patients with hypertension. Angiotensin II receptor blockers are thought to have greater beneficial effects than CCBs on coronary vasomotion by directly blocking action of angiotensin II. Twenty-six patients with untreated essential hypertension were prospectively assigned to treatment with either olmesartan (27.7 ± 12.4 mg/day, n = 13) or amlodipine (5.6 ± 1.5 mg/day, n = 13) for 12 weeks. Changes of corrected myocardial blood flow (ΔMBF) and coronary vascular resistance (ΔCVR) from rest to cold pressor were measured by using 15O-water and positron emission tomography before and after treatment. Blood biomarkers including lipids, glucose, insulin, high-sensitivity C-reactive protein, interleukin-6, tumor necrosis factor-alpha, and superoxide dismutase (SOD) were also measured. Olmesartan and amlodipine reduced blood pressure (BP) to the same extent (−28.7 ± 16.2 mm Hg vs. −26.7 ± 10.8 mm Hg). In the olmesartan group, ΔMBF tended to be greater (−0.15 ± 0.19 ml/g/min vs. 0.03 ± 0.17 ml/g/min, p = 0.09 by 2-way analysis of variance), and ΔCVR was significantly decreased (7.9 ± 23.5 mm Hg/[ml/g/min] vs. −16.6 ± 18.0 mm Hg/[ml/g/min], p < 0.05) after treatment, whereas these parameters did not change in the amlodipine group (ΔMBF: −0.15 ± 0.12 ml/g/min vs. −0.12 ± 0.20 ml/g/min; ΔCVR: 6.5 ± 18.2 mm Hg/[ml/g/min] vs. 4.8 ± 23.4 mm Hg/[ml/g/min]). Serum SOD activity tended to increase (4.74 ± 4.77 U/ml vs. 5.57 ± 4.74 U/ml, p = 0.07 by 2-way analysis of variance) only in the olmesartan group. Olmesartan, but not amlodipine, improved endothelium-dependent coronary dilation in hypertensive patients independent of BP reduction. These beneficial effects on coronary vasomotion might be via an antioxidant property of ARBs." @default.
• W2037589733 created "2016-06-24" @default.
• W2037589733 creator A5013813111 @default.
• W2037589733 creator A5014135006 @default.
• W2037589733 creator A5030373599 @default.
• W2037589733 creator A5037184379 @default.
• W2037589733 creator A5040440855 @default.
• W2037589733 creator A5046528941 @default.
• W2037589733 creator A5046674227 @default.
• W2037589733 creator A5091849037 @default.
• W2037589733 date "2007-09-01" @default.
• W2037589733 modified "2023-10-12" @default.
• W2037589733 title "Olmesartan, But Not Amlodipine, Improves Endothelium-Dependent Coronary Dilation in Hypertensive Patients" @default.
• W2037589733 cites W1555071216 @default.
• W2037589733 cites W1976555160 @default.
• W2037589733 cites W2014639523 @default.
• W2037589733 cites W2019338486 @default.
• W2037589733 cites W2022765475 @default.
• W2037589733 cites W2063967797 @default.
• W2037589733 cites W2065047436 @default.
• W2037589733 cites W2066605659 @default.
• W2037589733 cites W2089258822 @default.
• W2037589733 cites W2114369401 @default.
• W2037589733 cites W2124740644 @default.
• W2037589733 cites W2152043519 @default.
• W2037589733 cites W2167591703 @default.
• W2037589733 cites W2196103352 @default.
• W2037589733 doi "https://doi.org/10.1016/j.jacc.2007.06.013" @default.
• W2037589733 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17868805" @default.
• W2037589733 hasPublicationYear "2007" @default.
• W2037589733 type Work @default.
• W2037589733 sameAs 2037589733 @default.
• W2037589733 citedByCount "98" @default.
• W2037589733 countsByYear W20375897332012 @default.
• W2037589733 countsByYear W20375897332013 @default.
• W2037589733 countsByYear W20375897332014 @default.
• W2037589733 countsByYear W20375897332015 @default.
• W2037589733 countsByYear W20375897332016 @default.
• W2037589733 countsByYear W20375897332017 @default.
• W2037589733 countsByYear W20375897332018 @default.
• W2037589733 countsByYear W20375897332019 @default.
• W2037589733 countsByYear W20375897332020 @default.
• W2037589733 countsByYear W20375897332021 @default.
• W2037589733 crossrefType "journal-article" @default.
• W2037589733 hasAuthorship W2037589733A5013813111 @default.
• W2037589733 hasAuthorship W2037589733A5014135006 @default.
• W2037589733 hasAuthorship W2037589733A5030373599 @default.
• W2037589733 hasAuthorship W2037589733A5037184379 @default.
• W2037589733 hasAuthorship W2037589733A5040440855 @default.
• W2037589733 hasAuthorship W2037589733A5046528941 @default.
• W2037589733 hasAuthorship W2037589733A5046674227 @default.
• W2037589733 hasAuthorship W2037589733A5091849037 @default.
• W2037589733 hasBestOaLocation W20375897332 @default.
• W2037589733 hasConcept C104849204 @default.
• W2037589733 hasConcept C126322002 @default.
• W2037589733 hasConcept C134018914 @default.
• W2037589733 hasConcept C164705383 @default.
• W2037589733 hasConcept C2779646130 @default.
• W2037589733 hasConcept C2779766728 @default.
• W2037589733 hasConcept C2780356492 @default.
• W2037589733 hasConcept C2780972559 @default.
• W2037589733 hasConcept C2908929049 @default.
• W2037589733 hasConcept C71924100 @default.
• W2037589733 hasConcept C84393581 @default.
• W2037589733 hasConcept C98274493 @default.
• W2037589733 hasConceptScore W2037589733C104849204 @default.
• W2037589733 hasConceptScore W2037589733C126322002 @default.
• W2037589733 hasConceptScore W2037589733C134018914 @default.
• W2037589733 hasConceptScore W2037589733C164705383 @default.
• W2037589733 hasConceptScore W2037589733C2779646130 @default.
• W2037589733 hasConceptScore W2037589733C2779766728 @default.
• W2037589733 hasConceptScore W2037589733C2780356492 @default.
• W2037589733 hasConceptScore W2037589733C2780972559 @default.
• W2037589733 hasConceptScore W2037589733C2908929049 @default.
• W2037589733 hasConceptScore W2037589733C71924100 @default.
• W2037589733 hasConceptScore W2037589733C84393581 @default.
• W2037589733 hasConceptScore W2037589733C98274493 @default.
• W2037589733 hasFunder F4320320912 @default.
• W2037589733 hasFunder F4320321625 @default.
• W2037589733 hasFunder F4320321945 @default.
• W2037589733 hasIssue "12" @default.
• W2037589733 hasLocation W20375897331 @default.
• W2037589733 hasLocation W20375897332 @default.
• W2037589733 hasLocation W20375897333 @default.
• W2037589733 hasLocation W20375897334 @default.
• W2037589733 hasOpenAccess W2037589733 @default.
• W2037589733 hasPrimaryLocation W20375897331 @default.
• W2037589733 hasRelatedWork W2012375778 @default.
• W2037589733 hasRelatedWork W2030083921 @default.
• W2037589733 hasRelatedWork W2053932973 @default.
• W2037589733 hasRelatedWork W2065608861 @default.
• W2037589733 hasRelatedWork W2089173861 @default.
• W2037589733 hasRelatedWork W2273727769 @default.
• W2037589733 hasRelatedWork W2320446673 @default.
• W2037589733 hasRelatedWork W2368002165 @default.
• W2037589733 hasRelatedWork W2412535067 @default.
• W2037589733 hasRelatedWork W4241778831 @default.
• W2037589733 hasVolume "50" @default.

• next